107 related articles for article (PubMed ID: 20628431)
1. Selective in vivo antagonism of endothelin receptors in transforming growth factor-beta1 transgenic mice that mimic the vascular pathology of Alzheimer's disease.
Papadopoulos P; Ongali B; Hamel E
Can J Physiol Pharmacol; 2010 Jun; 88(6):652-60. PubMed ID: 20628431
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta 1 impairs endothelin-1-mediated contraction of brain vessels by inducing mitogen-activated protein (MAP) kinase phosphatase-1 and inhibiting p38 MAP kinase.
Tong XK; Hamel E
Mol Pharmacol; 2007 Dec; 72(6):1476-83. PubMed ID: 17848599
[TBL] [Abstract][Full Text] [Related]
3. Deleterious combined effects of salt-loading and endothelial cell restricted endothelin-1 overexpression on blood pressure and vascular function in mice.
Amiri F; Ko EA; Javeshghani D; Reudelhuber TL; Schiffrin EL
J Hypertens; 2010 Jun; 28(6):1243-51. PubMed ID: 20308920
[TBL] [Abstract][Full Text] [Related]
4. Endothelin receptor-mediated vasodilatation: effects of organ culture.
Nilsson D; Wackenfors A; Gustafsson L; Ugander M; Paulsson P; Ingemansson R; Edvinsson L; Malmsjö M
Eur J Pharmacol; 2008 Jan; 579(1-3):233-40. PubMed ID: 17964568
[TBL] [Abstract][Full Text] [Related]
5. Endothelin-1-induced pulmonary vasoreactivity is regulated by ET(A) and ET(B) receptor interactions.
Sauvageau S; Thorin E; Caron A; Dupuis J
J Vasc Res; 2007; 44(5):375-81. PubMed ID: 17495482
[TBL] [Abstract][Full Text] [Related]
6. Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction.
Amiri F; Virdis A; Neves MF; Iglarz M; Seidah NG; Touyz RM; Reudelhuber TL; Schiffrin EL
Circulation; 2004 Oct; 110(15):2233-40. PubMed ID: 15466627
[TBL] [Abstract][Full Text] [Related]
7. Transgenic mice overexpressing APP and transforming growth factor-beta1 feature cognitive and vascular hallmarks of Alzheimer's disease.
Ongali B; Nicolakakis N; Lecrux C; Aboulkassim T; Rosa-Neto P; Papadopoulos P; Tong XK; Hamel E
Am J Pathol; 2010 Dec; 177(6):3071-80. PubMed ID: 21088218
[TBL] [Abstract][Full Text] [Related]
8. Endothelial TRPV4 channels mediate dilation of cerebral arteries: impairment and recovery in cerebrovascular pathologies related to Alzheimer's disease.
Zhang L; Papadopoulos P; Hamel E
Br J Pharmacol; 2013 Oct; 170(3):661-70. PubMed ID: 23889563
[TBL] [Abstract][Full Text] [Related]
9. Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease.
Wyss-Coray T; Masliah E; Mallory M; McConlogue L; Johnson-Wood K; Lin C; Mucke L
Nature; 1997 Oct; 389(6651):603-6. PubMed ID: 9335500
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary fibrosis in L-NAME-treated mice is dependent on an activated endothelin system.
Kalk P; Mach A; Thone-Reineke C; Godes M; Heiden S; Sharkovska Y; von Websky K; Relle K; Hocher B
Can J Physiol Pharmacol; 2008 Aug; 86(8):541-5. PubMed ID: 18758502
[TBL] [Abstract][Full Text] [Related]
11. Reduced brain tissue perfusion in TGF-beta 1 transgenic mice showing Alzheimer's disease-like cerebrovascular abnormalities.
Gaertner RF; Wyss-Coray T; Von Euw D; Lesné S; Vivien D; Lacombe P
Neurobiol Dis; 2005; 19(1-2):38-46. PubMed ID: 15837559
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of endothelin A and B receptor antagonism on fetal growth in normal and nitric oxide-deficient rats.
Thaete LG; Neerhof MG; Silver RK
J Soc Gynecol Investig; 2001; 8(1):18-23. PubMed ID: 11223352
[TBL] [Abstract][Full Text] [Related]
13. Signalling and regulation of collagen I synthesis by ET-1 and TGF-beta1.
Horstmeyer A; Licht C; Scherr G; Eckes B; Krieg T
FEBS J; 2005 Dec; 272(24):6297-309. PubMed ID: 16336267
[TBL] [Abstract][Full Text] [Related]
14. Cerebral circulation: function and dysfunction in Alzheimer's disease.
Hamel E
J Cardiovasc Pharmacol; 2015 Apr; 65(4):317-24. PubMed ID: 25384195
[TBL] [Abstract][Full Text] [Related]
15. The neurogenic vasodilator response to endothelin-1: a study in human skin in vivo.
Katugampola R; Church MK; Clough GF
Exp Physiol; 2000 Nov; 85(6):839-46. PubMed ID: 11187978
[TBL] [Abstract][Full Text] [Related]
16. Losartan improves cerebrovascular function in a mouse model of Alzheimer's disease with combined overproduction of amyloid-β and transforming growth factor-β1.
Papadopoulos P; Tong XK; Imboden H; Hamel E
J Cereb Blood Flow Metab; 2017 Jun; 37(6):1959-1970. PubMed ID: 27389178
[TBL] [Abstract][Full Text] [Related]
17. Intact memory in TGF-β1 transgenic mice featuring chronic cerebrovascular deficit: recovery with pioglitazone.
Nicolakakis N; Aboulkassim T; Aliaga A; Tong XK; Rosa-Neto P; Hamel E
J Cereb Blood Flow Metab; 2011 Jan; 31(1):200-11. PubMed ID: 20571524
[TBL] [Abstract][Full Text] [Related]
18. Selective benefits of simvastatin in bitransgenic APPSwe,Ind/TGF-β1 mice.
Papadopoulos P; Tong XK; Hamel E
Neurobiol Aging; 2014 Jan; 35(1):203-12. PubMed ID: 23954171
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-β1 induces cerebrovascular dysfunction and astrogliosis through angiotensin II type 1 receptor-mediated signaling pathways.
Ongali B; Nicolakakis N; Tong XK; Lecrux C; Imboden H; Hamel E
Can J Physiol Pharmacol; 2018 May; 96(5):527-534. PubMed ID: 29505736
[TBL] [Abstract][Full Text] [Related]
20. Effect of chronic endothelin receptor antagonism on cerebrovascular function in type 2 diabetes.
Harris AK; Elgebaly MM; Li W; Sachidanandam K; Ergul A
Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1213-9. PubMed ID: 18287215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
